These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29404215)

  • 1. Equine glucagon-like peptide-1 receptor physiology.
    Kheder MH; Bailey SR; Dudley KJ; Sillence MN; de Laat MA
    PeerJ; 2018; 6():e4316. PubMed ID: 29404215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-2: A potential role in equine insulin dysregulation.
    de Laat MA; Fitzgerald DM; Sillence MN; Spence RJ
    Equine Vet J; 2018 Nov; 50(6):842-847. PubMed ID: 29502360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
    Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
    J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Effects of EGLP-1, a Novel Analog of Glucagon-Like Peptide-1, on Carbohydrate and Lipid Metabolism.
    Gao H; Song Z; Zhao Q; Wu Y; Tang S; Alahdal M; Shen Y; Xing Y; Pan Y; Li J; Zhang Y; Jin L
    Cell Physiol Biochem; 2018; 48(3):1112-1122. PubMed ID: 30041175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
    Flamez D; Gilon P; Moens K; Van Breusegem A; Delmeire D; Scrocchi LA; Henquin JC; Drucker DJ; Schuit F
    Diabetes; 1999 Oct; 48(10):1979-86. PubMed ID: 10512362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice.
    Gao H; Zhao Q; Li K; Qin F; Yin X; Lu Z; Song Z; Wu Y; Shen Y; Pan Y; Jin L; Yanfeng Zhang
    Exp Cell Res; 2021 Feb; 399(1):112454. PubMed ID: 33359447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glucagon-like peptide-1 receptor antagonist reduces the insulin response to a glycemic meal in ponies.
    de Laat MA; Fitzgerald DM; Harris PA; Bailey SR
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 38066683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical assessment of glucagon-like peptide 1 receptor (GLP-1R) expression in the pancreas of patients with type 2 diabetes.
    Kirk RK; Pyke C; von Herrath MG; Hasselby JP; Pedersen L; Mortensen PG; Knudsen LB; Coppieters K
    Diabetes Obes Metab; 2017 May; 19(5):705-712. PubMed ID: 28094469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in pancreatic islet cell function in response to small bowel resection.
    Courtney CM; Shyr ZA; Yan Z; Onufer EJ; Steinberger AE; Tecos ME; Barron LK; Guo J; Remedi MS; Warner BW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G36-G42. PubMed ID: 32463335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the GLP-1-GLP-1R axis in porcine pancreas and gastrointestinal tract in vivo by ex vivo autoradiography.
    Manell E; Puuvuori E; Svensson A; Velikyan I; Hulsart-Billström G; Hedenqvist P; Holst JJ; Jensen Waern M; Eriksson O
    BMJ Open Diabetes Res Care; 2021 Apr; 9(1):. PubMed ID: 33903116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
    Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.
    Gu W; Winters KA; Motani AS; Komorowski R; Zhang Y; Liu Q; Wu X; Rulifson IC; Sivits G; Graham M; Yan H; Wang P; Moore S; Meng T; Lindberg RA; Véniant MM
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E624-32. PubMed ID: 20647556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y; Ernst SA; Heidenreich K; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The equine glucose-dependent insulinotropic polypeptide receptor: A potential therapeutic target for insulin dysregulation.
    Kheder MH; Sillence MN; Bryant LM; de Laat MA
    J Anim Sci; 2017 Jun; 95(6):2509-2516. PubMed ID: 28727072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
    Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
    Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.
    Bullock BP; Heller RS; Habener JF
    Endocrinology; 1996 Jul; 137(7):2968-78. PubMed ID: 8770921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
    Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
    Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.